News for CareRx Corporation (CHHHF)

CareRx Corporation (TSX: CRRX) schedules its Q2 2025 financial results conference call for July 31, 2025. The financial results for the period ending Ju

Dive into the leadership attributes of great leaders, one by one, along with specific insights from amazing modern leaders across industries.

CareRx Corporation (CRRX) reported Q1 2025 revenue of $89.6 million, a slight decline from Q4 2024's $92.2 million. The company achieved a net income of

Revenue: $92.8 million in Q3 2024, down from $93.8 million in Q3 2023, but up from $92 million in Q2 2024.Adjusted EBITDA: $7.8 million in Q3 2024, a 6.2% incr

Revenue: $92 million for Q2 2024, down from $94.5 million in Q2 2023, up from $89.7 million in Q1 2024.Adjusted EBITDA: $7.5 million for Q2 2024, up 7% from $7

• • • • • This is an excerpt of the original content. To... | November 9, 2022

Read CareRx (OTCMKTS:CHHHF) Trading 11.9% Higher at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Shares Down 20.3% at ETF Daily News

Read CareRx Co. (OTCMKTS:CHHHF) Short Interest Down 12.5% in August at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Price Target Cut to C$6.00 by Analysts at Desjardins at ETF Daily News

Read Stifel Nicolaus Cuts CareRx (OTCMKTS:CHHHF) Price Target to C$6.50 at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Shares Down 6.1% at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Price Target Lowered to C$8.50 at Desjardins at ETF Daily News

Read CareRx Co. (OTCMKTS:CHHHF) Short Interest Update at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Price Target Lowered to C$8.00 at Canaccord Genuity Group at ETF Daily News